There are quite a few comments skeptical about whether this would actually prolong life, but that result is not the only possible benefit. Even keeping our same lifespan, but not picking up age-related diseases, aches and pains, and blindness would be a huge benefit to older folk. (And I mean those of us in our 40s and 50s, who already curtail activities due to aging, not just people over 80.)<p>Seriously, having been though some health problems, and seeing how much your quality of life can suffer, I think some people would willingly take a slightly shorter lifespan for increased quality of life as we age.<p>Are these drugs the answer? I have no clue. But the direction of the research is encouraging, no matter how long we all live.
In general in biology there is a simple criteria about the interest of an article:<p>- If it is tested in vitro, not only those results do not translate to human health issues (it is not in a living tissue which is a complex milieu, not simply the juxtaposition of cells), but commercial cell lines are not representative of normal cells, as they reproduce indefinitively.<p>- If it is tested on a mammalian animal model, it better but obviously mammalian species are different from each other at the organe level (for example the tail is used for thermoregulation in mouses).<p>- The best thing for evaluating any human impact, is a phase III of a clinical study.
This is largely a promo for Unity Biotechnology and the associated labs. It fails to mention, e.g. SIWA Therapeutics and their work on antibodies, Oisin Biotechnologies and their gene therapy DNA constructs for destroying cells based on internal chemistry, the company that David Sinclair is starting for senolytics, that Betterhumans has beaten Unity to the punch and is currently running phase 0 human pilots of dasatinib and quercetin on a non-profit basis. Also that senescent cell clearance didn't magically spring into being in 2011, but appears clearly in Aubrey de Grey's position paper on human rejuvenation in 2002, and the Methuselah Foundation, SENS Research Foundation, and others have been advocating hard for more work in this direction in the face of a research community that rejected it for a decade.<p>But hey, if you beat the competitors to be the first to raise 9-figure sums of venture capital, then you too can engineer attention to shine on you only, and rewrite history more or less as you like for a while.<p>So far all ways to address aging in mice have slowed aging by tinkering with metabolism, but slowing down the damage accumulation. They all produce much larger effects in short-lived species, probably because long-lived species have evolved to have many of these metabolic items turned on already. Calorie restriction extends life by 40% in mice, and I can assure you that while it is pretty beneficial in humans, you are not going to add more than a couple of extra years. Senescent cell clearance is the first way to address aging that involves repair of damage rather than slowing it down: we have no idea how the size of benefit in mice will translate to humans. So 25% gains in mice can be exciting here, whereas for any slowing-aging-only approach it would be a yawn.
Isn't this yet another case for keto/intermittent fasting? It is well known that in a fasting state you trigger cell autophagy -> essentially force healthy cells to eat dead or diseased cells for energy...
The longevity benefits of fasting/caloric-restriction also appear to work through the clearing of some cells ('autophagy'); see for example:<p><a href="https://en.wikipedia.org/wiki/Autophagy#Caloric_restriction" rel="nofollow">https://en.wikipedia.org/wiki/Autophagy#Caloric_restriction</a>
Took me a while to find, but this method apparently only increases the life span of mice by 25%. Given how mice are prey animals - i.e. they aren't meant to live long - I don't anticipate the same results with Humans. Although, it may help reduce risks of diseases.<p>It'll be interesting to see results.
Some papers showing direct connections between senescent cells and specific aspects of aging, in many cases turning back that aspect by removing the senescent cells.<p>Osteoporosis: <a href="https://doi.org/10.1038/nm.4385" rel="nofollow">https://doi.org/10.1038/nm.4385</a><p>Fatty liver disease: <a href="https://doi.org/10.1038/ncomms15691" rel="nofollow">https://doi.org/10.1038/ncomms15691</a><p>Disruption of platelet formation: <a href="https://doi.org/10.3389/fonc.2017.00188" rel="nofollow">https://doi.org/10.3389/fonc.2017.00188</a><p>Osteoarthritis: <a href="https://dx.doi.org/10.1038/nm.4324" rel="nofollow">https://dx.doi.org/10.1038/nm.4324</a><p>Disruption of regeneration: <a href="https://doi.org/10.3389/fcell.2017.00049" rel="nofollow">https://doi.org/10.3389/fcell.2017.00049</a><p>Lung fibrosis: <a href="https://doi.org/10.1183/13993003.02367-2016" rel="nofollow">https://doi.org/10.1183/13993003.02367-2016</a><p>Pulmonary function in general, including tissue elasticity: <a href="https://doi.org/10.1172/jci.insight.87732" rel="nofollow">https://doi.org/10.1172/jci.insight.87732</a><p>Atherosclerosis: <a href="http://dx.doi.org/10.1126/science.aaf6659" rel="nofollow">http://dx.doi.org/10.1126/science.aaf6659</a><p>Vascular calcification: <a href="http://dx.doi.org/10.18632/aging.101191" rel="nofollow">http://dx.doi.org/10.18632/aging.101191</a><p>Chronic kidney disease: <a href="https://doi.org/10.18632/oncotarget.17327" rel="nofollow">https://doi.org/10.18632/oncotarget.17327</a><p>Cardiac hypertrophy: <a href="https://doi.org/10.1371/journal.pone.0182668" rel="nofollow">https://doi.org/10.1371/journal.pone.0182668</a><p>Cardiac fibrosis and function in general: <a href="https://doi.org/10.1093/eurheartj/ehx454" rel="nofollow">https://doi.org/10.1093/eurheartj/ehx454</a>
I would be surprised if people weren't already testing this, e.g. in China where there is less regulation.<p>I think that could be a trend: US/European researcher publishes hypothesis, and Asian researcher secretly tests it on humans, and if it works, publishes it and/or becomes first to market.
I wonder if exercising contributes to killing off these senescent cells. In muscle building one is breaking down and rebuilding muscle cells, this might as well prevent cell "aging" and going into senescence.
Just thinking about the societal implications of this. For example, death is one of the few things that causes turnover in the Senate.<p>It seems ironic that the mechanism here (killing off old cells) enables humans to live longer, thereby possibly enabling these same humans to case society to age.
Not going to prevent aging as well as people think.<p>As cells age, the risk for mutations occuring when they divide increases. The reason these cells stop dividing and become senescent is because dividing elderly cells poses a high cancer risk.<p>I think this may buy the trappings of youth (plump skin, clear eyes, etc) at the cost of a higher risk of cancer.
Summary: Kill cells that have stopped dividing, but that are still alive. (Called: Senescent cells.)<p>Don't prevent them from entering this state (which could cause tumors), just kill them if they do enter this state.<p>Hard part: Each organ/tissue has different types of cells, so each needs a unique medication to kill those cells.